Gao Y, Chen S, Jiao S, Fan Y, Li X, Tan N
Autophagy. 2024; 20(6):1398-1417.
PMID: 38368631
PMC: 11210915.
DOI: 10.1080/15548627.2024.2319512.
Lopez-Perez M, Jain A, Davies D, Vasquez-Jimenez J, Herrera S, Onate J
Sci Rep. 2024; 14(1):2790.
PMID: 38307966
PMC: 10837454.
DOI: 10.1038/s41598-024-53175-0.
Stanisic D, Good M
BioDrugs. 2023; 37(6):737-756.
PMID: 37728713
PMC: 10581939.
DOI: 10.1007/s40259-023-00623-4.
El-Moamly A, El-Sweify M
Trop Med Health. 2023; 51(1):29.
PMID: 37198702
PMC: 10189698.
DOI: 10.1186/s41182-023-00516-w.
Imai T, Ngo-Thanh H, Suzue K, Shimo A, Nakamura A, Horiuchi Y
Vaccines (Basel). 2022; 10(5).
PMID: 35632518
PMC: 9145751.
DOI: 10.3390/vaccines10050762.
Selective Targeting of Breast Cancer by Tafuramycin A Using SMA-Nanoassemblies.
El-Deeb I, Pittala V, Eltayeb D, Greish K
Molecules. 2021; 26(12).
PMID: 34207832
PMC: 8227162.
DOI: 10.3390/molecules26123532.
Whole-Killed Blood-Stage Vaccine: Is It Worthwhile to Further Develop It to Control Malaria?.
Cai J, Chen S, Zhu F, Lu X, Liu T, Xu W
Front Microbiol. 2021; 12:670775.
PMID: 33995336
PMC: 8119638.
DOI: 10.3389/fmicb.2021.670775.
A whole parasite transmission-blocking vaccine for malaria: an ignored strategy.
Good M, Yanow S
Emerg Top Life Sci. 2021; 1(6):547-552.
PMID: 33525845
PMC: 7289001.
DOI: 10.1042/ETLS20170117.
Malaria vaccines since 2000: progress, priorities, products.
Duffy P, Gorres J
NPJ Vaccines. 2020; 5(1):48.
PMID: 32566259
PMC: 7283239.
DOI: 10.1038/s41541-020-0196-3.
A genetically hmgb2 attenuated blood stage P. berghei induces crossed-long live protection.
Briquet S, Lawson-Hogban N, Peronet R, Mecheri S, Vaquero C
PLoS One. 2020; 15(5):e0232183.
PMID: 32379764
PMC: 7205229.
DOI: 10.1371/journal.pone.0232183.
The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design.
Mitran C, Yanow S
Front Immunol. 2020; 11:335.
PMID: 32174924
PMC: 7056716.
DOI: 10.3389/fimmu.2020.00335.
Identification of Plasmodium falciparum circumsporozoite protein-specific CD8+ T cell epitopes in a malaria exposed population.
Kusi K, Aggor F, Amoah L, Anum D, Nartey Y, Amoako-Sakyi D
PLoS One. 2020; 15(2):e0228177.
PMID: 32040522
PMC: 7010280.
DOI: 10.1371/journal.pone.0228177.
A step forward for an attenuated blood-stage malaria vaccine.
Burns Jr J
BMC Med. 2018; 16(1):204.
PMID: 30409141
PMC: 6225678.
DOI: 10.1186/s12916-018-1197-1.
Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
Low L, Ssemaganda A, Liu X, Ho M, Ozberk V, Fink J
Infect Immun. 2018; 87(1).
PMID: 30323025
PMC: 6300636.
DOI: 10.1128/IAI.00587-18.
Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
Stanisic D, Fink J, Mayer J, Coghill S, Gore L, Liu X
BMC Med. 2018; 16(1):184.
PMID: 30293531
PMC: 6174572.
DOI: 10.1186/s12916-018-1173-9.
Induction of immunity following vaccination with a chemically attenuated malaria vaccine correlates with persistent antigenic stimulation.
Reiman J, Kumar S, Rodriguez I, Gnidehou S, Ito K, Stanisic D
Clin Transl Immunology. 2018; 7(4):e1015.
PMID: 29670745
PMC: 5894007.
DOI: 10.1002/cti2.1015.
Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium.
Coelho C, Doritchamou J, Zaidi I, Duffy P
NPJ Vaccines. 2018; 2:34.
PMID: 29522056
PMC: 5709382.
DOI: 10.1038/s41541-017-0035-3.
Immunization with Transgenic Rodent Malaria Parasites Expressing Pfs25 Induces Potent Transmission-Blocking Activity.
Sala K, Angrisano F, Da D, Taylor I, Churcher T, Blagborough A
Sci Rep. 2018; 8(1):1573.
PMID: 29371619
PMC: 5785477.
DOI: 10.1038/s41598-017-18831-8.
Protein-Specific Features Associated with Variability in Human Antibody Responses to Malaria Antigens.
Liu E, Skinner J, Tran T, Kumar K, Narum D, Jain A
Am J Trop Med Hyg. 2017; 98(1):57-66.
PMID: 29141757
PMC: 5928716.
DOI: 10.4269/ajtmh.17-0437.
Evaluation of a Plasmodium-Specific Carrier Protein To Enhance Production of Recombinant s25, a Leading Transmission-Blocking Vaccine Candidate.
Parzych E, Miura K, Ramanathan A, Long C, Burns Jr J
Infect Immun. 2017; 86(1).
PMID: 28993460
PMC: 5736822.
DOI: 10.1128/IAI.00486-17.